FDA Submits Proposed Collection of Information for Review and Clearance Under Paperwork Reduction Act

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, as required by the Paperwork Reduction Act of 1995, in order to obtain certification to accompany drug, biological product, and device applications or submissions, as outlined in Form FDA 3674.